Medifocus develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”). The company owns two technology platforms with approximately 100 issued and pending U.S. and international patents on which MDFZF has developed two advanced therapeutic products: the Adaptive Phased Array (APA)-1000 system for treatment of breast cancer and the Prolieve® system for the treatment of BPH. For more information visit the company’s Web site at www.medifocusinc.com
Let us hear your thoughts below: